Arcturus Therapeutics Holdings Inc (ARCT)
17.06
+0.90
(+5.53%)
USD |
NASDAQ |
Nov 21, 16:00
17.03
-0.04
(-0.21%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Max Drawdown (5Y): 90.09% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 90.09% |
| September 30, 2024 | 90.09% |
| August 31, 2024 | 92.78% |
| July 31, 2024 | 94.21% |
| June 30, 2024 | 94.21% |
| May 31, 2024 | 96.20% |
| April 30, 2024 | 96.20% |
| March 31, 2024 | 96.20% |
| February 29, 2024 | 97.15% |
| January 31, 2024 | 97.24% |
| December 31, 2023 | 97.41% |
| November 30, 2023 | 97.65% |
| October 31, 2023 | 97.65% |
| September 30, 2023 | 97.65% |
| August 31, 2023 | 97.65% |
| July 31, 2023 | 97.65% |
| June 30, 2023 | 97.65% |
| May 31, 2023 | 97.65% |
| April 30, 2023 | 97.65% |
| March 31, 2023 | 97.65% |
| February 28, 2023 | 97.65% |
| January 31, 2023 | 97.65% |
| December 31, 2022 | 97.65% |
| November 30, 2022 | 97.65% |
| October 31, 2022 | 97.65% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.65% |
| August 31, 2022 | 97.65% |
| July 31, 2022 | 97.65% |
| June 30, 2022 | 97.65% |
| May 31, 2022 | 97.65% |
| April 30, 2022 | 97.65% |
| March 31, 2022 | 97.65% |
| February 28, 2022 | 97.65% |
| January 31, 2022 | 97.65% |
| December 31, 2021 | 97.65% |
| November 30, 2021 | 97.65% |
| October 31, 2021 | 97.65% |
| September 30, 2021 | 97.65% |
| August 31, 2021 | 97.65% |
| July 31, 2021 | 97.65% |
| June 30, 2021 | 97.65% |
| May 31, 2021 | 97.65% |
| April 30, 2021 | 97.65% |
| March 31, 2021 | 97.65% |
| February 28, 2021 | 97.65% |
| January 31, 2021 | 97.65% |
| December 31, 2020 | 97.65% |
| November 30, 2020 | 97.65% |
| October 31, 2020 | 97.65% |
| September 30, 2020 | 97.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.09%
Minimum
Sep 2024
97.65%
Maximum
Nov 2019
97.11%
Average
97.65%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Fulcrum Therapeutics Inc | -- |
| Bioventus Inc | -- |
| Liquidia Corp | -- |
| Pfizer Inc | 54.78% |
| AIM ImmunoTech Inc | 99.76% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.54 |
| Beta (5Y) | 2.640 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 127.0% |
| Historical Sharpe Ratio (5Y) | 0.0593 |
| Historical Sortino (5Y) | 0.1878 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.32% |